• Data privacy
  • Legal notices
  • Deutsch Deutsch German de
  • English English English en
Cenata GmbH | Paul-Ehrlich-Str. 23 | D-72076 Tübingen | Germany | Tel. +49 7071 - 565 44 430 | Fax +49 7071 - 565 44 444
Harmony-Logo
Cenata GmbH
  • The Harmony® Test
  • For physicians
    • For physicians
    • Harmony® Test procedure
    • Aspects of counseling
    • Limitations of the Harmony® Test
    • Congresses
    • Useful links
    • Downloads
  • For expectant parents
    • For expectant parents
    • Harmony® Test procedure
    • Understanding the results
    • Information on numerical chromosomal disorders
    • Information on X and Y chromosomal disorders
    • DiGeorge syndrome (Microdeletion 22q11.2)
    • Reimbursement of costs
    • Useful links for parents
    • FAQ
    • Downloads
  • Services
    • Services
    • Downloads
    • Order sampling kit
    • Partnering
    • Contact
  • About Cenata
    • About Cenata
    • News
  • Search
  • Menu

Reliable test.

Secure decision.

Understanding the results

Negative (normal) test result

The Harmony® Test assesses the risk of trisomies 21, 18 and 13 and, upon request, the risk of numerical changes to the sex chromosomes X and Y or the risk of DiGeorge syndrome. In the event of a negative test result with no pathological ultrasound findings, you can rule out the tested disorders in your unborn child with a high degree of probability.

The exception is trisomy 13, for which latest figures show a detection rate of 85 – 90% of cases by non-invasive tests of maternal blood (NIPT). This chromosomal disorder, however, is very rare, with a frequency of 1:10000 (depending on the mother’s age)1 and can be easily detected by an ultrasound scan, e.g. during first trimester screening.

The Harmony® Test is able to detect 75% of all 22q11.2 microdeletions, including those smaller than 3 Mb at a false-positive rate of 0.5% 2. The screening for DiGeorge syndrome by the Harmony® Test determines the probability for the presence of the genetic disorder, however, it is not able to ascertain the clinical severity of the microdeletion.

All NIPT methods have limits when it comes to the detection of mosaics or structural chromosomal changes. The Harmony® Test only investigates the most common chromosomal disorders, so it cannot identify any physical disorders in the child; therefore a negative (normal) test result does not rule out the possibility of other disorders in your unborn child. A number of these disorders can be detected with an accurate ultrasound scan, often from the 12th week of pregnancy. A genetic test such as the Harmony® Test can never replace a thorough ultrasound scan.

If you have any further questions your physician will be pleased to help during your entire pregnancy. You can also contact our team of physicians at any time should you have any questions.

Positive (abnormal) test result

If the Harmony® Test returns a positive (abnormal) result, there is a relatively high probability that your child has one of the tested chromosomal disorders. However, since the test can also produce a false-positive result, a positive (abnormal) finding must always be confirmed by a second diagnostic, invasive method (chorionic villus sampling or amniocentesis). Subsequent chromosome analysis of those samples can then provide definitive diagnostic results. Within the scope of genetic counseling, your physician will explain in detail the possible effects of the probable chromosomal disorder for your unborn child and provide you with information about further counseling options.

  1. U.S. National Library of Medicine. Genetics Home Reference. Trisomy 13. ↩
  2. Schmid M et al. Prenatal Screening for 22q11.2 Deletion Using a Targeted Microarray-Based Cell-Free DNA Test.Fetal Diagn Ther. 2017 Nov 8, E-pub ahead of print ↩

For expectant parents

  • For expectant parents
  • Harmony® Test procedure
  • Understanding the results
  • Information on numerical chromosomal disorders
  • Information on X and Y chromosomal disorders
  • DiGeorge syndrome (Microdeletion 22q11.2)
  • Reimbursement of costs
  • Useful links for parents
  • Downloads
  • FAQ

Search

About Cenata

  • About Cenata
  • Quality Management
  • News

Order sampling kit

    Service exclusively for medical practices and clinics.

    Sampling kits

    Brochure for patients

    Educational brochure

    Brochure for physicians

    Information for DiGeorge syndrome

    Yes, I have read the data privacy and I do agree to it. Data privacy

    Contact

      Yes, I have read the data privacy and I do agree to it. Data privacy

      © 2016 Roche Diagnostics and Cenata GmbH. All rights reserved. Cenata® and the Cenata-Logo are registered trademarks of Cenata GmbH. HARMONY® is a registered trademark of Roche. All other trademarks are the property of their respective owners.
      Scroll to top